Alyeska Investment Group, L.P.

Position in AZN — Astrazeneca PLC

CIK 1453072 CHICAGO, IL

Position in AZN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$209,502,467

New position

Shares Held

1,062,278

first reported quarter

Ownership

0.068%

of shares outstanding

% of Portfolio

0.64%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Alyeska Investment Group, L.P. holds $1,016,752,962 across 7 Drug Manufacturers - General names. AZN ranks #2 (20.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	2,305,574	$277,337,496
2	AZN	Astrazeneca PLC This page	1,062,278	$209,502,467
3	JNJ	Johnson & Johnson	834,692	$204,032,112
4	BIIB	Biogen Inc.	805,050	$147,589,816
5	SNY	Sanofi	2,306,229	$111,114,113
6	GSK	GSK plc	1,210,746	$66,821,071
7	NVO	Novo Nordisk A S	9,684	$355,887

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$209,502,467	1,062,278	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.